News
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Novavax has been available since 2022 through a pandemic-era Emergency Use Authorization. A decision on full approval – which ...
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its ...
Novavax said on Wednesday the U.S. Food and Drug Administration had asked the company to produce more data on its COVID-19 ...
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
With full FDA approval, Novavax would have permission ... the spike protein. The Pfizer and Moderna options deliver genetic instructions for the body to temporarily make copies of the protein.
It is still being sold under emergency use authorization — unlike mRNA vaccines made by Pfizer and Moderna that have earned full FDA approval for certain age groups. The FDA recently asked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results